• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Future implications of polygenic risk scores for life insurance underwriting.

作者信息

Yanes Tatiane, Tiller Jane, Haining Casey M, Wallingford Courtney, Otlowski Margaret, Keogh Louise, McInerney-Leo Aideen, Lacaze Paul

机构信息

Frazer Institute, The University of Queensland, Dermatology Research Centre, Brisbane, QLD, Australia.

Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.

出版信息

NPJ Genom Med. 2024 Mar 30;9(1):25. doi: 10.1038/s41525-024-00407-x.

DOI:10.1038/s41525-024-00407-x
PMID:38555372
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10981684/
Abstract
摘要

相似文献

1
Future implications of polygenic risk scores for life insurance underwriting.多基因风险评分对人寿保险承保的未来影响。
NPJ Genom Med. 2024 Mar 30;9(1):25. doi: 10.1038/s41525-024-00407-x.
2
Genetic risk scores in life insurance underwriting.人寿保险承保中的遗传风险评分。
J Health Econ. 2022 Jan;81:102556. doi: 10.1016/j.jhealeco.2021.102556. Epub 2021 Nov 15.
3
Structured settlement annuities, part 1: overview and the underwriting process.结构性结算年金，第1部分：概述与承保流程。
J Insur Med. 2000;32(3):131-6.
4
Age dependent decline of relative risks in life insurance medical underwriting.人寿保险医学核保中相对风险的年龄依赖性下降。
J Insur Med. 2014;44(3):170-83.
5
Multi-criteria decision-making methods applied in health-insurance underwriting.多标准决策方法在健康保险承保中的应用。
Health Syst (Basingstoke). 2022 Jun 19;12(1):52-84. doi: 10.1080/20476965.2022.2085190. eCollection 2023.
6
Policy implications of an annuity approach to integrating long-term care financing and retirement income.年金方式在整合长期护理融资与退休收入方面的政策影响。
J Aging Health. 2003 Feb;15(1):45-73. doi: 10.1177/0898264302239014.
7
Disability insurance: can underwriting criteria for the self-employed be based on predictors used for disability amongst employees?伤残保险：个体经营者的承保标准能否基于适用于雇员伤残情况的预测指标？
J Insur Med. 2006;38(4):259-70.
8
Long-term care insurance underwriting: understanding eventual claims experience.长期护理保险承保：了解最终理赔经验。
Inquiry. 2000;37(4):348-58.
9
[Expert systems in risk assessment. Risk or opportunity?].[风险评估中的专家系统。风险还是机遇？]
Versicherungsmedizin. 1997 Jun 1;49(3):94-6, 98, 100.
10
Risky business: long-term care insurance underwriting.风险业务：长期护理保险承保
Inquiry. 1995 Fall;32(3):271-84.

引用本文的文献

1
Standardization, Education, and Resourcing: The Way Forward for Implementing Polygenic Risk Scores in Hereditary Breast and Ovarian Cancer.标准化、教育与资源配置：遗传性乳腺癌和卵巢癌中实施多基因风险评分的未来之路
Clin Transl Sci. 2025 Aug;18(8):e70323. doi: 10.1111/cts.70323.
2
Genetic discrimination in insurance and employment based on personalized risk stratification for breast cancer screening.基于乳腺癌筛查个性化风险分层的保险和就业中的基因歧视。
Front Genet. 2025 Mar 5;16:1481863. doi: 10.3389/fgene.2025.1481863. eCollection 2025.
3
Polygenic Risk Score (PRS) Combined with NGS Panel Testing Increases Accuracy in Hereditary Breast Cancer Risk Estimation.多基因风险评分（PRS）联合二代测序（NGS）panel检测可提高遗传性乳腺癌风险评估的准确性。
Diagnostics (Basel). 2024 Aug 21;14(16):1826. doi: 10.3390/diagnostics14161826.
4
Promoting equity in polygenic risk assessment through global collaboration.通过全球合作促进多基因风险评估中的公平性。
Nat Genet. 2024 Sep;56(9):1780-1787. doi: 10.1038/s41588-024-01843-2. Epub 2024 Aug 5.

本文引用的文献

1
Australian researcher's perspectives on the Australian industry-led moratorium on genetic tests in life insurance.澳大利亚研究人员对澳大利亚保险业主导的基因检测暂停令的看法。
Am J Med Genet A. 2024 Jun;194(6):e63565. doi: 10.1002/ajmg.a.63565. Epub 2024 Feb 14.
2
Financial Advisers' and Key Informants' Perspectives on the Australian Industry-Led Moratorium on Genetic Tests in Life Insurance.金融顾问和主要知情人对澳大利亚行业主导的寿险基因检测暂停的看法。
Public Health Genomics. 2023;26(1):123-134. doi: 10.1159/000533532. Epub 2023 Aug 14.
3
Genetic discrimination by insurance companies in Aotearoa New Zealand: experiences and views of health professionals.新西兰的保险公司对遗传信息的歧视：健康专业人员的经验和看法。
N Z Med J. 2023 Apr 28;136(1574):32-52. doi: 10.26635/6965.6116.
4
Fairness and Risk: An Ethical Argument for a Group Fairness Definition Insurers Can Use.公平与风险：关于保险公司可采用的群体公平定义的伦理论证。
Philos Technol. 2023;36(3):45. doi: 10.1007/s13347-023-00624-9. Epub 2023 Jun 19.
5
Community concerns about genetic discrimination in life insurance persist in Australia: A survey of consumers offered genetic testing.澳大利亚的消费者在提供基因检测后，对寿险中的基因歧视仍存在担忧：一项消费者调查。
Eur J Hum Genet. 2024 Mar;32(3):286-294. doi: 10.1038/s41431-023-01373-1. Epub 2023 May 11.
6
Human Genetics Society of Australasia Position Statement: Use of Polygenic Scores in Clinical Practice and Population Health.澳大拉西亚人类遗传学学会立场声明：多基因分数在临床实践和人群健康中的应用。
Twin Res Hum Genet. 2023 Feb;26(1):40-48. doi: 10.1017/thg.2023.10. Epub 2023 Mar 23.
7
The clinical application of polygenic risk scores: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG).多基因风险评分的临床应用：美国医学遗传学与基因组学学会（ACMG）的一份要点声明
Genet Med. 2023 May;25(5):100803. doi: 10.1016/j.gim.2023.100803. Epub 2023 Mar 15.
8
Perceived benefits and barriers to implementing precision preventive care: Results of a national physician survey.实施精准预防保健的感知益处和障碍：一项全国医生调查的结果。
Eur J Hum Genet. 2023 Nov;31(11):1309-1316. doi: 10.1038/s41431-023-01318-8. Epub 2023 Feb 20.
9
Clinical genetic counseling and translation considerations for polygenic scores in personalized risk assessments: A Practice Resource from the National Society of Genetic Counselors.临床遗传咨询和多基因评分在个性化风险评估中的翻译注意事项：美国遗传咨询师协会的实践资源。
J Genet Couns. 2023 Jun;32(3):558-575. doi: 10.1002/jgc4.1668. Epub 2023 Jan 8.
10
Preferences for a polygenic test to estimate cancer risk in a general Australian population.普通澳大利亚人群中用于评估癌症风险的多基因检测的偏好。
Genet Med. 2022 Oct;24(10):2144-2154. doi: 10.1016/j.gim.2022.07.011. Epub 2022 Aug 10.